HEALTH● LOWJul 10 · Jul 10, 2026, 11:29 AM
GSK partner Hansoh posts late-stage trial win for lung cancer drug in China
Seeking Alpha Tech
A partner of GSK, Hansoh, has successfully completed a late-stage trial for a lung cancer drug in China. This development marks progress in the pharmaceutical industry's efforts to treat lung cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH46m ago‘Be alive’: Hongkonger with muscular dystrophy turns 18, against all oddsSouth China Morning PostHEALTH1h agoMaharashtra FDA issues order to curb sale, repackaging of expired food itemsThe HinduHEALTH2h agoEpidermolysis Bullosa and patients' fight against stigmatization: "Calling us butterfly skin doesn't help at all"ClarínHEALTH2h agoEbola scare in Adamawa: NCDC confirms negative testsVanguard Nigeria